For instance, reduced CTR1 expression in specific tumor cells limits copper ion influx, diminishing the efficacy of chemotherapy drugs—particularly platinum-based agents that depend on copper metabolism—thereby contributing to drug resistance. Here, SLC31A1 is linked to neoplasm.